Intracerebral xenotransplantation of GFP mouse bone marrow stromal cells in intact and stroke rat brain: Graft survival and immunologic response

被引:45
作者
Irons, H
Lind, JG
Wakade, CG
Yu, G
Hadman, M
Carroll, J
Hess, DC
Borlongan, CV
机构
[1] Med Coll Georgia, Dept Neurol, Augusta, GA 30912 USA
[2] Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA
[3] Med Coll Georgia, Sch Grad Studies, Augusta, GA 30912 USA
[4] Augusta Vet Adm Med Ctr, Res & Affiliat Serv Line, Augusta, GA 30912 USA
关键词
neural transplantation; cerebral ischemia; immunosuppression; striatum lymphocytes; cyclosporin A; graft cell migration; neuronal phenotype;
D O I
10.3727/000000004783983990
中图分类号
Q813 [细胞工程];
学科分类号
摘要
The present study characterized survival and immunologic response of bone marrow stromal cells (BMSCs) following transplantation into intact and stroke brains. In the first study, intrastriatal transplantation of BMSC (60.000 in 3 mul) or vehicle was performed in normal adult Sprague-Dawley male rats that subsequently received daily cyclosporin A (CsA, 10 mg/kg, IP in 3 ml) or vehicle (olive oil. similar volume) starting on day of surgery up to 3 days posttransplantation. Animals were euthanized at 3 or 30 days posttransplantation and brains were processed either for green fluorescent protein (GFP) microscopy or flow cytometry (FACS). Both GFP epifluorescence and FACS scanning revealed GFP+ BMSCs in both groups of transplanted rats with or without CsA, although significantly increased (1.6- to 3-fold more) survival of GFP+ BMSCs was observed in the immunosuppressed animals. Further histologic examination revealed widespread dispersal of BMSCs away from the graft core accompanied by many long outgrowth processes in non-CsA-transplanted animals. whereas a very dense graft core, with cells expressing only sporadic short outgrowth processes. was observed in CsA-transplanted animals. There were no detectable GFP+ BMSCs in nontransplanted rats that received CsA or vehicle. Immunologic response via FACS analysis revealed a decreased presence of cytotoxic cells, characterized by near complete absence of CD8+ cells, and lack of activation depicted by low CD69 expression in CsA-treated transplanted animals. In contrast, elevated levels of CD8+ cells and increased activation of CD69 expression were observed in transplanted animals that received vehicle alone. CD4+ helper cells were almost nondetectable in transplanted rats that received CsA, but also only minimally elevated in transplanted rats that received vehicle. Nontransplanted rats that received either CsA or vehicle displayed very minimal detectable levels of all three lymphocyte markers. In the second study, a new set of male Sprague-Dawley rats initially received bilateral stereotaxic intrastriatal transplantation of BMSCs and 3, days after were subjected to unilateral transient occlusion of middle cerebral artery. The animals were allowed to survive for 3 days after stroke without CsA immunosuppression. Epifluorescence microscopy revealed significantly higher (5-Fold more) survival of transplanted GFP+ BMSCs in the stroke striatum compared with the intact striatum. The majority of the g-rafts remained within the original dorsal striatal transplant site, characterized by no obvious migration in intact striatum, but with long-distance migration along the ischemic penumbra in the stroke striatum. Moreover, FACS scanning analyses revealed low levels of immunologic response of grafted BMSCs in both stroke and intact striata. These results. taken together, suggest that xenotransplantation of mouse BMSCs into adult rats is feasible. Immunosuppression therapy can enhance xenograft survival and reduce graft-induced immunologic response; however, in the acute phase posttransplantation, BMSCs can survive in intact and stroke brain. and may even exhibit long-distance migration and increased out growth processes without immunosuppression.
引用
收藏
页码:283 / 294
页数:12
相关论文
共 85 条
[1]   Porcine neural xenografts in the immunocompetent rat: Immune response following grafting of expanded neural precursor cells [J].
Armstrong, RJE ;
Harrower, TP ;
Hurelbrink, CB ;
McLaughin, M ;
Ratcliffe, EL ;
Tyers, P ;
Richards, A ;
Dunnett, SB ;
Rosser, AE ;
Barker, RA .
NEUROSCIENCE, 2001, 106 (01) :201-216
[2]   Regulation of dopamine cell type and transmitter function in fetal and stem cell transplantation for Parkinson's disease [J].
Björklund, LM ;
Isacson, O .
PLASTICITY IN THE ADULT BRAIN: FROM GENES TO NEUROTHERAPY, 2002, 138 :411-420
[3]   Viability and survival of hNT neurons determine degree of functional recovery in grafted ischemic rats [J].
Borlongan, CV ;
Saporta, S ;
Poulos, SG ;
Othberg, A ;
Sanberg, PR .
NEUROREPORT, 1998, 9 (12) :2837-2842
[4]   Transplantation of cryopreserved human embryonal carcinoma-derived neurons (NT2N cells) promotes functional recovery in ischemic rats [J].
Borlongan, CV ;
Tajima, Y ;
Trojanowski, JQ ;
Lee, VMY ;
Sanberg, PR .
EXPERIMENTAL NEUROLOGY, 1998, 149 (02) :310-321
[5]   Early assessment of motor dysfunctions aids in successful occlusion of the middle cerebral artery [J].
Borlongan, CV ;
Hida, H ;
Nishino, H .
NEUROREPORT, 1998, 9 (16) :3615-3621
[6]   Glial cell survival is enhanced during melatonin-induced neuroprotection against cerebral ischemia [J].
Borlongan, CV ;
Yamaoto, M ;
Takei, N ;
Kumazaki, M ;
Ungsuparkorn, C ;
Hida, H ;
Sanberg, PR ;
Nishino, H .
FASEB JOURNAL, 2000, 14 (10) :1307-1317
[7]   Facilitation of drug entry into the CNS via transient permeation of blood brain barrier: laboratory and preliminary clinical evidence from bradykinin receptor agonist, Cereport [J].
Borlongan, CV ;
Emerich, DF .
BRAIN RESEARCH BULLETIN, 2003, 60 (03) :297-306
[8]   Cyclosporine A-induced hyperactivity in rats: Is it mediated by immunosuppression, neurotrophism, or both? [J].
Borlongan, CV ;
Stahl, CE ;
Fujisaki, T ;
Sanberg, PR ;
Watanabe, S .
CELL TRANSPLANTATION, 1999, 8 (01) :153-159
[9]   Cerebral ischemia and CNS transplantation: differential effects of grafted fetal rat striatal cells and human neurons derived from a clonal cell line [J].
Borlongan, CV ;
Tajima, Y ;
Trojanowski, J ;
Lee, VMY ;
Sanberg, PR .
NEUROREPORT, 1998, 9 (16) :3703-3709
[10]   Bradykinin receptor agonist facilitates low-dose Cyclosporine-A protection against 6-hydroxydopamine neurotoxicity [J].
Borlongan, CV ;
Emerich, DF ;
Hoffer, BJ ;
Bartus, RT .
BRAIN RESEARCH, 2002, 956 (02) :211-220